Patients with interstitial cystitis/bladder pain syndrome (IC/BPS) suffer from chronic pain that severely affects quality of life. Although the underlying pathophysiology is not well understood, inhibition of bladder sensory afferents temporarily relieves pain. Here, we explored the possibility that optogenetic inhibition of bladder sensory afferents could be used to modulate bladder pain. Specifically, we chose to study the role of Na v 1.8 + sensory afferents before and after induction of a mouse model of bladder pain. The light-activated inhibitory proton pump Archaerhodopsin (Arch) was expressed under control of the Na v 1.8 + promoter to selectively silence these neurons. Optically silencing Na v 1.8 + afferents significantly blunted the evoked visceromotor response to bladder distension and led to small but significant changes in bladder function. To study of the role of these fibers in freely behaving mice, we developed a fully implantable, flexible, wirelessly powered optoelectronic system for the long-term manipulation of bladder afferent expressed opsins. We found that optogenetic inhibition of Na v 1.8 + fibers reduced both ongoing pain and evoked cutaneous hypersensitivity in the context of cystitis, but had no effect in uninjured, naïve mice. These results suggest that selective optogenetic silencing of bladder afferents may represent a potential future therapeutic strategy for the treatment of bladder pain.
Introduction:
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating pelvic pain syndrome of unknown etiology 1, 2 . IC/BPS patients experience chronic pelvic pain symptoms, including pain on bladder filling, increased urinary urgency and frequency as the primary clinical symptoms [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Blocking afferent drive from the bladder by instillation of local anesthetics has long been known to reduce bladder pain in many patients with IC/BPS 13, 14 . More targeted desensitization of C-fiber afferents using resiniferatoxin (a potent TRPV1 agonist) has also been demonstrated to reduce bladder pain in IC/BPS patients, suggesting that targeted strategies to silence bladder nociceptive afferents hold promise for the clinical management of IC/BPS 15, 16 .
The TTX-resistant sodium channel Na v 1.8 is expressed in nociceptor populations that respond predominantly to capsaicin and inflammatory mediators [17] [18] [19] . Previous studies have shown the expression of Na v 1.8 in C-fiber afferent neurons that innervate the bladder 20, 21 .
Additionally, C-fiber bladder afferent neurons that express Na v 1.8 exhibit increased excitability after induction of bladder cystitis 22 . Recent studies demonstrate that rodents in which Na v 1.8 gene is deleted or suppressed, exhibit diminished bladder nociceptive responses and referred hyperalgesia after induction of cystitis 23, 24 . These results suggest that selective silencing of primary afferent neurons expressing Na v 1.8 could be an effective strategy for treating inflammation-induced bladder pain. However, the major caveat with these knockdown studies is that it is hard to control for compensatory upregulation of other Na v channels. To overcome this obstacle, we took advantage of optogenetic techniques that can specifically and reversibly inhibit this specific population of neurons.
Archaerhodopsin (Arch), is a light-activated proton pump, which upon activation by green light (520-590 nm), induces membrane hyperpolarization and robustly suppresses neuronal firing 25, 26 . Previous studies have shown that transdermal illumination of Arch expressed in Na v 1.8 + peripheral nerve terminals innervating the paw results in a significant decrease in somatic pain, suggesting that optogenetics can be used to effectively silence the peripheral nociceptors during chronic pain 27, 28 . are NF200-positive (Fig. 1A) , 41± 0.1% are CGRP-positive (Fig. 1B ) and 32 ± 3.1% are IB4-positive (Fig. 1C) . Whole mount staining of the bladder wall of Na v 1.8-Arch mice showed that Arch-GFP-positive fibers co-label with the neuronal marker β3-tubulin, suggesting that Arch-GFP is effectively transported to afferent endings in the bladder (Fig. 1D ).
We performed whole-cell patch clamp electrophysiology recordings on cultured DRG neurons from Na v 1.8-Arch mice to verify functional expression of Arch in Na v 1.8 + bladder sensory afferents. We identified bladder-projecting neurons, using the retrograde dye, DiI, injected into the bladder wall and then recorded from bladder-projecting (DiI + , red) and Arch-GFP + (green) cell bodies (Fig 2A) . In voltage clamp, illumination of Arch-GFP-expressing bladder-projecting neurons with green light (530 nm) induced robust outward currents (Fig. 2B ).
This current was sufficient to suppress action potential firing in response to ramp current injections in all neurons tested ( Fig. 2C -D, *** p=0.001. n=7 neurons; Paired t test).
Optogenetic inhibition of bladder sensory afferent terminals attenuates distensioninduced pain and voiding behavior. We next tested if inhibition of Na v 1.8 + bladder sensory terminals could attenuate bladder pain in response to distension. Bladder pain was assessed by the visceromotor response (VMR), evoked by bladder distention (10-60 mmHg distention in 10 mmHg steps, as we have described previously 34, 35 We determined if optogenetic inhibition of Na v 1.8 + bladder afferents influences urodynamics by performing cystometric analysis of bladder function before and during laser illumination of the bladder (Fig. 4A) . In anesthetized Na v 1.8-Arch mice, illumination of bladder afferents with green light did not significantly alter maximum pressure, baseline pressure or threshold pressure between control or Na v 1.8-Arch mice (Fig. 4 B, C) . However, we did observe a slight (15.05%), yet statistically significant increase in the intercontraction interval (ICI) during laser illumination of the bladder in Na v 1.8-Arch mice compared to control mice (Fig. 4 B- , to fabricate a flexible optoelectronic device to specifically target light to the lower abdomen. These devices are powered by near field communication (NFC) technology to achieve robust wireless functionality for chronic applications and for use in a wide variety of behavioral arenas ( . This PIB barrier allowed for 100% of the devices to function for at least 4 weeks after implantation in the animal, with more than 50% of devices remaining functional after 6 months and some devices still functional at > 9 months after implantation.
These small and flexible optoelectronic devices can be adapted to a wide array of behavioral or home cage environments by tuning flexible signal antennas specifically for the dimensions of the behavioral or home cage environment. Figure 5D shows an example of the experimental setup for power transmission from antenna to optoelectronic devices in a V-maze (experimental data in Fig. 6B and C). The double-loop antenna is installed around the perimeter of one arm of the maze; for optimal power output performance, the loop antennae are placed 2.5 cm and 7.5 cm from the bottom of the cage. The spatial uniformity of power is demonstrated by equal illumination of twelve optoelectronic devices placed at different locations in a V-maze cage (Fig. 5D ). This antenna configuration also allows for uniform μ-ILED illumination on the vertical dimension as well, which is important for maintaining consistent illumination during mouse rearing (Fig. 5E ). The output power is normalized by its value at the center of double loop antenna at 5 cm and provides evidence that deviation of output power from the double loop antenna is less than 20%. This result indicates that the position of the double-loop antennas allows for a uniform magnetic field within the cage. This powering scheme allows for consistent and uniform illumination of implanted µ-ILEDs, which is critically important to reduce variability in light delivery during optogenetic experiments.
We also determined the heat generation under operation conditions by measuring the temperature at the surface of the device, in the mouse as a function of time, at peak output In the naïve state, both wild type and Na v 1.8 + -Arch mice exhibited no preference for either the LED ON or LED OFF arms (Na v 1.8-Arch LED ON vs LED OFF, p=0.6606, n= 6 mice per group, two-way ANOVA) ( Fig. 6C; E) . However, after CYP-induced cystitis, Na v 1.8 + -Arch mice showed significant RTPP for the LED ON arm compared to the LED OFF arm, whereas wild type mice with CYP-induced cystitis show no preference (Na v 1.8-Arch LED ON vs LED OFF, ### p=0.0065, n= 11 mice per group, two-way ANOVA) ( Fig. 6D-F) . These results suggest that inhibition of Na v 1.8 + bladder sensory afferents attenuates both ongoing pain and referred abdominal hypersensitivity in a mouse model of bladder pain.
Discussion:
The cardinal clinical symptoms of IC/BPS include pain upon bladder filling (distention) and inhibiting bladder sensory afferents can reduce this pain in many patients. Prior studies have demonstrated that the majority of bladder-projecting C-fiber neurons express Na v 1.8-mediated Na 2+ currents 20, 46 . In addition, C-fiber bladder afferents that express Na v 1.8 channels are known to exhibit increased excitability in animal models of bladder pain, suggesting the importance of these afferents in mediating bladder nociception 23, 24 . We confirmed the assumptions made by these original studies 23,24 by specifically inhibiting Na v 1.8 + bladder
afferents with the inhibitory channel Arch expressed under the control of the Na v 1.8 promoter and demonstrated that these fibers play a critical role in bladder nociception and a minor role in bladder voiding.
Previous studies have shown that C-fibers are silent during normal bladder distension and can become active during bladder injury. Thus, C-fiber activity is thought to contribute to bladder nociception in response to injury and have a sparse role in innocuous sensation of the bladder under normal physiological conditions 20, [46] [47] [48] [49] . Consistent with these reports, we find that inhibition of Na v 1.8 + bladder sensory afferents significantly attenuates nociception related to bladder injury induced by CYP and has no effect in naïve mice.
Somewhat surprisingly, in our cystometry studies, we found that silencing Na v 1.8 + bladder sensory afferents resulted in a small yet significant increase in the ICI in naïve Na v 1.8-Arch mice. The first possible explanation for this is that the relatively non-physiological, rapid rate of bladder filling in continuous flow cystometry engages nociceptive afferents to a small degree and inhibition of these afferents leads to delays in ICI. Alternatively, the effect of silencing Na v 1.8 + afferents on bladder function may not be due to Na v 1.8 expression in small diameter nociceptors. Indeed, consistent with a prior report 50 , we demonstrate that a proportion of Na v 1.8 + bladder-projecting neurons co-express NF200 (42 ± 10.9%), a marker of large myelinated sensory neurons. It is possible that these cells include low threshold mechanoreceptors, which are known to be involved in the voiding reflex 51, 52 . Thus, this population of bladder afferents contributes to the delay in ICI we observe after optically silencing Nav1.8 + bladder afferents.
A limitation of using VMR to measure bladder nociception is that these experiments must be performed in lightly anesthetized mice, and the response is evoked with invasive bladder distention. The fully implantable wireless NFC-powered µ-ILED devices we developed offer the ability to optically control neural activity in awake (un-anesthetized) and freely behaving mice. . The bladder is easily accessible to these innovative approaches.
Combining any of these gene therapy approaches that prove to be safe with real-time control of neural dynamics with closed-loop optoelectronic systems 56-59 could lead to the development of future therapies for bladder pain and/or voiding dysfunction. The wireless devices we have developed could be easily scaled for use in humans, and our results suggest that optogenetic silencing of Na v 1.8 + bladder afferents could be an effective approach to alleviate pain associated with IC/BPS.
Materials and Methods:

Animals and genetic strategy
Adult mice (8-12 weeks of age) were used for this study, unless otherwise noted. Mice were housed in the animal facilities of the Washington University School of Medicine on a 12 h light/dark cycle, with ad libitum access to food and water. Institutionally approved protocols were followed for all aspects of this study. Experiments were performed on male heterozygous 
Visceromotor reflex behavior
The visceromotor reflex (VMR) in female mice was quantified using abdominal electromyograph (EMG) responses. The VMR is a reliable behavioral index of visceral nociception in rodents and was performed as previously described [60] [61] [62] [63] [64] . Briefly, mice were anesthetized with isoflurane (2% in oxygen) and silver wire electrodes were placed in the oblique abdominal muscle. A lubricated, 24-gauge angiocatheter was passed into the bladder via the urethra for urinary bladder distension (UBD). After surgical preparation, isoflurane was reduced to ∼1% until a flexion reflex response was present (evoked by pinching the paw), but righting reflex was absent. Phasic UBD consisted of graded distensions at pressures of 10-60 mmHg. Baseline EMG activity was subtracted from EMG during UBD, rectified, and integrated to obtain distension-evoked EMG responses. Distension-evoked EMG is presented as area under the curve. Experimenter was blinded to mouse genotype. For more detailed methods see supplementary methods.
Cystometry
Mice (8-22 weeks old) were first anesthetized with isoflurane (2%), then a midline incision was used to expose the bladder dome. A 25-gauge butterfly needle was used to puncture the dome of the bladder and warm mineral oil placed on the exposed bladder to prevent tissue drying.
After the catheter was placed, anesthesia was lowered to 1.5% for 1 hour. Then over 30-40 minutes, the anesthesia was slowly reduced to ~0.8%. At this point, bladders were filled at 0.04 ml/min with room-temperature water or saline (no differences observed between fluids; data not shown) using a syringe pump to evoke a regular voiding pattern. Intravesicular pressure was measured using a pressure transducer amplified by a Transbridge transducer amplifier (WPI) and recorded using WINDAQ data acquisition software (DataQ Instruments) at a sampling rate of 5 Hz. After a regular voiding pattern was established, a ten-minute baseline was collected followed by laser illumination (described below) for at least ten minutes and a ten-minute recovery period. The laser was always turned on at the end of a contraction and then off at the end of a contraction resulting in some trials that were greater than ten-minutes. These trials were completed in duplicate for each animal and parameters were averaged. Data were analyzed using a Matlab (Mathworks) script to determine base pressure (BP), threshold
pressure (TP), maximum pressure (MP) and intercontraction interval (ICI) (terminology conformed to 65
). All data files were blinded so analysis could occur in an unbiased manner.
Photoinhibition of VMR and Cystometry
Optical inhibition of VMR was performed using a 532 nm, 200 mW diode-pumped solid-state 
NFC device fabrication
Micro-fabrication of the soft, flexible wireless optoelectronic devices started with a spincast poly(dimethylsiloxane) (PDMS, Sylgard 184) at 600 RPM x 60 second on a clean glass slide (75 x 50 x 1 mm, L x W x thickness), followed by curing at 150°C x 10 min. Next, an 8% by weight solution of polyisobutylene (PIB, BASF) in heptane was applied to freshly cured PDMS by spin-casting at 1000 RPM x 60 second followed by a 3 min bake at 100°C. Then copper foil (18 μm thickness) was placed on the newly formed polymer substrate. Photolithography (AZ 4620, AZ Electronic Materials) and copper etching was then used to define the conducting pattern. Next, the electronic components (μ-ILED (TR2227, 540 nm, Cree Inc. Raleigh, NC), rectifier (CBDQR0130L-HF, Comchip Technology, Freemont, CA), and 136 pF capacitor (GRM1555C1H680JA01J, Murata electronics, Japan)) were placed onto the copper pattern using conductive paste. Then a second layer of polyisobutylene was added to the device, followed by another PDMS layer, using the same conditions described above.
Implantation of wireless NFC device
The NFC optoelectronic devices were used to activate Arch in freely moving mice. Under isoflurane anesthesia, a small incision was made in the abdominal skin and the device was implanted subcutaneously between the skin and muscle, positioned to illuminate the lower abdomen and bladder. The incision was then closed using surgical staples. The animals were allowed to recover for at least 4 days before behavioral experiments were performed.
Cyclophosphamide (CYP) induced cystitis
Cyclophosphamide (CYP) was used to induce bladder inflammation and visceral pain. 
Abdominal mechanical sensitivity
Abdominal sensitivity was measured by counting the number of withdrawal responses to 10 applications of von Frey filaments (North Coast Medical, Inc, Gilroy, CA; 0.02, 0.08, 0.32 and 1.28 g) to the lower abdomen. Each mouse was allowed at least 15 seconds between each application and at least 5 minutes between each size filament. Animals were acclimated to individual boxes on a plastic screen mesh for at least one hour before testing. All experimenters were blinded to mouse genotype and treatment. NFC devices were activated by an antenna wrapped around the individual cage, prior to the experiment the antenna was tested to insure full NFC coverage of the cage. NFC antenna power and signal were generated by Neurolux hardware and software (Neurolux, Urbana, IL).
Real-time place preference (RTPP)
Place preference was tested in a custom made V-maze constructed of plexiglass with a layer of corn cob bedding. Each arm of the two-arm V maze is 10 cm wide × 30 cm long x 10 cm height neutral area between arms. To generate the NFC signal, one arm of the maze was covered with an NFC-emitting antenna (Neurolux, Urbana, IL) allowing for the control of µ-ILED devices throughout one arm of the maze. To begin the experimental protocol, a mouse was placed in the neutral area of the maze and was continuously monitored and recorded through a video connection for 20 min. Ethovision software (Noldus, Leesburg, VA.) was used to determine time-in-chamber and generate representative heat maps for each condition.
Statistics
Results are expressed as means ± SEM. 
